A research team at the University of Konstanz, led by toxicologist Ivano Amelio, has demonstrated how differently individual mutations of the tumor suppressor p53 affect pancreatic carcinomas.
Theseus Pharmaceuticals lays off most workers and seeks ‘strategic alternatives’ after cancer pipeline failure
Theseus Pharmaceuticals said after Monday’s closing bell that it will let go of 72% of its workforce, or about 26 people, and will seek “strategic alternatives”
November 15, 2023